Publications by authors named "Sang-Gon Park"

Purpose: Tumor suppressor p53 (TP53) mutations are common in head and neck squamous cell carcinoma (HNSCC). We evaluated their clinical impact in patients treated with targeted agents or immunotherapy in the KCSG HN15-16 TRIUMPH trial.

Materials And Methods: We analyzed clinical characteristics and outcomes of patients with TP53 mutations in the TRIUMPH trial, a multicenter, biomarker-driven umbrella trial in Korea.

View Article and Find Full Text PDF

Background/aim: This study examined the role of GNAO1 as a potential tumor suppressor gene in colorectal cancer (CRC).

Materials And Methods: RNA-seq data analysis revealed a significant GNAO1 down-regulation in colon cancer tissues compared to normal colon tissues.

Results: GNAO1 over-expression in CRC cell lines inhibited cell proliferation, migration, and tumor formation both in vitro and in vivo.

View Article and Find Full Text PDF

Background: Immune checkpoint inhibitor (ICI) or irinotecan-based chemotherapy is frequently used after failure of second-line paclitaxel plus ramucirumab treatment for patients with locally advanced unresectable or metastatic advanced gastric cancer (AGC). This study aimed to compare the efficacy between ICI and irinotecan-based chemotherapy as third-line treatment in patients with AGC.

Methods: We retrospectively reviewed patients with AGC, whose third-line treatment started between July 2019 and June 2021 at 17 institutions in Korea.

View Article and Find Full Text PDF
Article Synopsis
  • This study evaluates the efficacy of a combination treatment (ABCP) involving atezolizumab, bevacizumab, paclitaxel, and carboplatin for patients with non-small-cell lung cancer who have progressed after tyrosine kinase inhibitor therapy.
  • The results show that the ABCP treatment led to significantly better objective response rates and progression-free survival compared to the traditional treatment (PC), particularly in patients with higher PD-L1 expression.
  • Overall survival rates were similar between both treatment groups, and while ABCP had a comparable safety profile, it was associated with higher rates of treatment-related side effects compared to the PC arm.
View Article and Find Full Text PDF
Article Synopsis
  • - This study investigated a targeted treatment approach for patients with platinum-refractory recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC) through a genomic profile-based trial involving multiple treatment arms.
  • - Patients were assigned to different treatment groups based on their genetic profiles, with various inhibitors used, and crossover to an anti-PD-L1 treatment was allowed if their initial therapy failed.
  • - The trial enrolled 203 patients and found varying levels of disease control and response rates across different arms, while the treatments were generally well-tolerated with no treatment-related deaths reported.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the expression of PD-L1, an immune checkpoint protein, in non-small cell lung cancer (NSCLC) using three different commercial clones to ensure reliable testing for immunotherapy eligibility.
  • - Researchers analyzed 76 lung cancer cases through immunohistochemistry and found varying levels of PD-L1 expression across the three clones: 25% scored ≥50% with clone 22C3PharmDx, while clones SP263 and SP142 showed different proportions of positive scores.
  • - The findings indicate that all three PD-L1 clones are effective for detecting targets for cancer immunotherapies, but accurate evaluation by pathologists is critical to avoid misinterpretations.
View Article and Find Full Text PDF

Background: Following the global outbreak of coronavirus disease 2019 (COVID-19), unlike other vaccines, COVID-19 vaccines were developed and commercialized in a relatively short period of time. The large-scale administration of this vaccine in a short time-period led to various unexpected side effects, including severe cytopenia and thrombosis with thrombocytopenia syndrome. Despite many reports on adverse reactions, vaccination was necessary to prevent the spread of COVID-19; thus, it is essential to understand and discuss various cases of adverse reactions after vaccination.

View Article and Find Full Text PDF

Background: Non-secretory multiple myeloma (MM) is a rare condition that accounts for only 3% of MM cases and is defined by normal serum and urine immunofixation and a normal serum free light chain ratio. Non-secretory MM with multiple extramedullary plasmacytomas derived from endobronchial lesions is extremely rare and can be misdiagnosed as metastasis of solid cancer.

Case Summary: A 36-year-old man presented with progressive facial swelling and nasal congestion with cough.

View Article and Find Full Text PDF

The Hsp70-binding protein 1 (HspBP1) belongs to a family of co-chaperones that regulate Hsp70 activity and whose biological significance is not well understood. In the present study, we show that when HspBP1 is either knocked down or overexpressed in BRCA1-proficient breast cancer cells, there were profound changes in tumorigenesis, including anchorage-independent cell growth in vitro and in tumor formation in xenograft models. However, HspBP1 did not affect tumorigenic properties in BRCA1-deficient breast cancer cells.

View Article and Find Full Text PDF

Background: Sjogren's syndrome (SS), which affect salivary gland function, is an autoimmune disease. SS may involve extraglandular organs. Approximately 10 to 20 percent of SS patients have clinically significant lung disease, but presentation of pulmonary amylodosis is extremly rare.

View Article and Find Full Text PDF

Genetic differences may be associated with the response to tyrosine kinase inhibitor (TKI) in patients with chronic myeloid leukemia (CML). In this study, we identified genetic alterations between rapid and slow responders (BCR/ABL1 International Scale at 6 months: ≤0.1 % vs.

View Article and Find Full Text PDF

Ultra-deep sequencing detects low-frequency genetic mutations with high sensitivity. We used this approach to prospectively examine mutations in the BCR/ABL1 tyrosine kinase from patients with newly diagnosed, chronic-phase chronic myeloid leukemia (CML) treated with the tyrosine kinase inhibitor nilotinib. Between May 2013 and November 2014, 50 patients from 18 institutions were enrolled in the study.

View Article and Find Full Text PDF

Background/aim: Previous reports have indicated that increased expression of Jagged-1 (JAG1) may predict chemotherapy response and poor prognosis for patients with recurrent or metastatic colorectal cancer (CRC). This study aimed to investigate the clinical impact of JAG1 expression level in patients with CRC, including recurrence, especially in those diagnosed with lymph node-positive stage III CRC who underwent complete resection and appropriate adjuvant chemotherapy.

Patients And Methods: All patients were enrolled through a retrospective chart review, and only those for whom the clinical course and all clinical information were adequately determined according to the inclusion criteria were selected for retrospective review through medical records.

View Article and Find Full Text PDF

Background: The roots of (AJN), called "Useul-puli," has been traditionally used to control pain and improve dysfunction in osteoarthritis patients in South Korea.

Case Summary: We described 3 patients diagnosed with herbal medicine induced interstitial lung disease after consuming boiled the roots of AJN. They were referred to our hospital because of the modified Medical Research Council grade 4 dyspnea.

View Article and Find Full Text PDF

Background: Arsenic trioxide (ATO) is recommended for patients who do not achieve molecular remission or who have molecular or morphologic relapse. However, there are no guidelines for adjusting ATO dosage in patients with severe renal failure or on dialysis. Herein, we report the successful treatment of relapsed acute promyelocytic leukemia (APL) in a patient on hemodialysis with ATO single agent and review the cases in literature.

View Article and Find Full Text PDF

Background: Ovarian undifferentiated carcinomas are significantly rare and have an aggressive clinical course. Surgical resection is the only curative treatment in early-stage ovarian undifferentiated carcinomas that has a favorable prognosis. In case of recurrent and metastatic disease, palliative chemotherapy is the only available treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Pembrolizumab is an antibody that targets PD-1, showing significant effectiveness and safety for treating non-small cell lung cancer (NSCLC) compared to traditional chemotherapy.
  • A 79-year-old man with lung squamous cell carcinoma and metastatic disease was treated with chemotherapy, but his condition progressed, leading to the initiation of pembrolizumab, resulting in a complete tumor response after 3 cycles.
  • However, after the 4th cycle of treatment, the patient developed acute myelomonocytic leukemia, marking the first known case of this leukemia occurring during pembrolizumab therapy, with the cause still unclear.
View Article and Find Full Text PDF

Background/aim: We investigated the clinical role of the molecular targets, APEX1 and Jagged-1, and the Apex1 - Jagged-1 cascade in gastric cancer cells.

Materials And Methods: We used 6 human gastric cancer cell lines (SNU-1, SNU-5, SNU-16, NCI-N87, KATO- III and AGS), and demonstrated the chemosensitivity of APEX1 and Jagged-1 through the MTT assay and immunoblotting. Tumor growth was assayed following cisplatin and 5-FU treatment using a xenograft model injected with KATO-III cells.

View Article and Find Full Text PDF

Background: Post-transplant lymphoproliferative disorder (PTLD) is a fatal complication of solid organ transplantation or allogenic hematopoietic stem cell transplantation that is associated with immunosuppressive therapy. Potential manifestations are diverse, ranging from reactive lymphoid hyperplasia to high-grade lymphoma. PTLD is usually of B-cell origin and associated with Epstein-Barr virus (EBV) infection.

View Article and Find Full Text PDF

Background/aim: Colorectal cancer (CRC) is one of the most common in the world and its prevalence is rapidly increasing. Jagged-1-activated Notch signaling by apurinic/apyrimidinic endodeoxyribonuclease 1 (APEX1) promotes CRC, and high expression of Jagged-1 is associated with poor prognosis. However, its clinical implication is unknown.

View Article and Find Full Text PDF

Background/aim: Droplet digital polymerase chain reaction (ddPCR) is an exact method of measuring nucleic acids. The aim of this prospective study was to evaluate minimal residual disease (MRD) using ddPCR in chronic myeloid leukemia (CML) patients.

Patients And Methods: Between May 2013 and November 2014, CML patients treated with nilotinib were enrolled in our study.

View Article and Find Full Text PDF

Background: Bronchobiliary fistula (BBF) is a rare disease characterized by an abnormal connection between the biliary system and bronchi. Traditional causes of BBF include trauma and infections, and more recent causes include malignancies and certain cancer treatments. Ramucirumab is an antivascular endothelial growth factor receptor 2 monoclonal antibody, currently used as a second-line treatment for gastric cancer.

View Article and Find Full Text PDF

Hepatic fibrosis results from chronic liver injury and inflammatory responses. Sestrin 2 (Sesn2), an evolutionarily conserved antioxidant enzyme, reduces the severities of acute hepatitis and metabolic liver diseases. However, the role of Sesn2 in the pathogenesis of liver fibrosis remains obscure.

View Article and Find Full Text PDF

BACKGROUND Tumor lysis syndrome (TLS) is an oncologic emergency resulting from the massive destruction of tumor cells after cytotoxic chemotherapy for chemosensitive malignancies with a high tumor burden. Its clinical manifestations include severe electrolyte disturbances, metabolic acidosis, acute renal failure secondary to urate deposition in the kidney, heart, and skeletal muscle, and nervous system dysfunction. We report an extremely rare case of spontaneous TLS (STLS) in idiopathic primary myelofibrosis (PMF).

View Article and Find Full Text PDF